Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Addition of suberoylanilide hydroxamic acid (Vorinostat) to azacitidine for patients with higher risk myelodysplastic syndromes and azacitidine failure: a phase II add-on study from the Groupe Francophone des Myelodysplasies.

Literature DB >> 27977052

Addition of suberoylanilide hydroxamic acid (Vorinostat) to azacitidine for patients with higher risk myelodysplastic syndromes and azacitidine failure: a phase II add-on study from the Groupe Francophone des Myelodysplasies.

Abstract

Entities: Chemical Disease Species

Keywords: epigenetic; myelodysplasia; myeloid leukaemia; relapse

Year: 2016 PMID： 27977052 DOI： 10.1111/bjh.14427

Source DB: PubMed Journal: Br J Haematol ISSN： 0007-1048 Impact factor: 6.998

× No keyword cloud information.

2 in total

Authors: Natalie Uy; Abhay Singh; Steven D Gore; Thomas Prebet
Journal: Expert Opin Pharmacother Date: 2017-08-01 Impact factor: 3.889

Authors: Hye In Kim; Seok Kyo Seo; Seung Joo Chon; Ga Hee Kim; Inha Lee; Bo Hyon Yun
Journal: Int J Mol Sci Date: 2021-01-31 Impact factor: 5.923

2 in total